Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Overall Study	STARTED	20vPnC	1,006
Overall Study	STARTED	13vPnC	505
Overall Study	Dose 1	20vPnC	1,000
Overall Study	Dose 1	13vPnC	504
Overall Study	Dose 2	20vPnC	972
Overall Study	Dose 2	13vPnC	492
Overall Study	Dose 3	20vPnC	964
Overall Study	Dose 3	13vPnC	483
Overall Study	Dose 4	20vPnC	923
Overall Study	Dose 4	13vPnC	462
Overall Study	COMPLETED	20vPnC	910
Overall Study	COMPLETED	13vPnC	451
Overall Study	NOT COMPLETED	20vPnC	96
Overall Study	NOT COMPLETED	13vPnC	54

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04379713/flow